Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Therapy-Optimization Trial and Phase II Study for the Treatment of Relapsed or Refractory of Primitive Neuroectodermal Brain Tumors and Ependymomas in Children and Adolescents

NCT00749723 is registered in ClinicalTrials.gov with University Hospital, Bonn as lead sponsor.

NCT NCT00749723
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00749723 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Therapy-Optimization Trial and Phase II Study for the Treatment of Relapsed or Refractory of Primitive Neuroectodermal Brain Tumors and Ependymomas in Children and Adolescents
Lead sponsor
University Hospital, Bonn
Phase
Phase 2/3
Overall status
Completed
Start date
February 1, 2006
Completion date
January 31, 2016
Enrollment
174 (actual)
Sites
54

Conditions

As the registry lists them; a condition with its own page is linked.

ependymomas, medulloblastomas, recurrent brain tumors, supratentorial pnets